Gamma-secretase inhibitor does not modulate angiogenesis in colon adenocarcinoma in obese mice

Abstract

Insights

This study investigated the effect of γ-secretase inhibitor (DAPT) on tumor angiogenesis in diet-induced obese mice. DAPT altered serum angiogenic factors but did not modulate tumor angiogenesis.

Area of Science:

  • Oncology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Notch signaling is crucial for angiogenesis.
  • γ-secretase is essential for Notch processing.
  • Obesity can influence tumor microenvironment and angiogenesis.

Purpose of the Study:

  • To investigate the effect of γ-secretase inhibitor (DAPT) on tumor angiogenesis in diet-induced obese mice.
  • To analyze the impact of DAPT on serum angiogenic factors and tumor capillary density.

Main Methods:

  • Diet-induced obesity model in mice.
  • Tumor induction using CT26 colon adenocarcinoma cells.
  • Administration of DAPT and subsequent analysis of serum markers and tumor immunohistochemistry.

Main Results:

  • Obese mice showed elevated leptin and NO, but similar VEGF and VEGFR-1 compared to controls.
  • DAPT treatment in obese mice reduced serum VEGFR-1 and leptin, and increased NO.
  • Tumor capillary density was not significantly altered by DAPT in obese mice.

Conclusions:

  • DAPT modifies serum angiogenic factors in obese mice.
  • DAPT does not modulate tumor angiogenesis in this diet-induced obesity model.
  • Further research is needed to understand the complex interplay between obesity, Notch signaling, and tumor angiogenesis.

Related Concept Videos